Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
in response to
by
posted on
Nov 23, 2018 10:44AM
Bear I should add to the last point, that Bioasis is now seeking approval for a clinical trial.
Is that correct?
" xB3-001 attached to Trastuzumab helps it (TZM) to cross the BBB to attack HER2- expressing breast cancer that has spread to the brain. "
Koo